Spyre Therapeutics, Inc.
SYRE
DELAYED 1 MONTH
15 insider filings · Latest: Jun 3, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Jun 4 1:32 AM | Sheldon SloanChief Medical Officer | Sale | 8,333 | $75.00 | $625.0K | 0(D) | View → |
| Jun 1, 2026 | Jun 4 1:31 AM | Cameron TurtleDirector, Chief Executive Officer | Sale | 15,000 | $70.43 | $1.1M | 597,540(D) | View → |
| Jun 1, 2026 | Jun 4 1:30 AM | Scott L BurrowsChief Financial Officer | Sale | 7,500 | $71.06 | $532.9K | 97,994(D) | View → |
| May 8, 2026 | May 9 1:31 AM | Michael Thomas HendersonDirector | Sale | 80,000 | $74.40 | $6.0M | 88,606(D) | View → |
| May 1, 2026 | May 2 1:35 AM | Scott L BurrowsChief Financial Officer | Sale | 12,500 | $71.37 | $892.1K | 97,994(D) | View → |
| May 1, 2026 | May 2 1:34 AM | Sheldon SloanChief Medical Officer | Sale | 78,333 | $71.50 | $5.6M | 0(D) | View → |
| May 1, 2026 | May 2 1:34 AM | Cameron TurtleDirector, Chief Executive Officer | Sale | 15,000 | $71.37 | $1.1M | 612,540(D) | View → |
| Mar 3, 2026 | Mar 4 2:32 AM | Scott L BurrowsChief Financial Officer | Sale | 2,500 | $40.65 | $101.6K | 97,994(D) | View → |
| Mar 2, 2026 | Mar 4 2:31 AM | Cameron TurtleDirector, Chief Executive Officer | Sale | 15,000 | $42.19 | $632.9K | 642,540(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Jun 4 1:32 AM | Sheldon SloanChief Medical Officer | Option Exercise | 8,333 | $27.46 | 313,334(D) | View → |
| Jun 1, 2026 | Jun 4 1:30 AM | Scott L BurrowsChief Financial Officer | Option Exercise | 7,500 | $14.50 | 374,857(D) | View → |
| May 27, 2026 | May 29 9:58 PM | Fairmount Funds Management LLCDirector | Grant/Award | 8,026 | $72.51 | 8,026(I) | View → |
| May 27, 2026 | May 29 9:56 PM | Jeffrey W. AlbersDirector | Grant/Award | 8,026 | $72.51 | 8,026(D) | View → |
| May 27, 2026 | May 29 9:55 PM | Michael Thomas HendersonDirector | Grant/Award | 8,026 | $72.51 | 8,026(D) | View → |
| May 27, 2026 | May 29 9:55 PM | Laurie StelzerDirector | Grant/Award | 8,026 | $72.51 | 8,026(D) | View → |
| May 27, 2026 | May 29 9:55 PM | Mark C. MckennaDirector | Grant/Award | 8,026 | $72.51 | 8,026(D) | View → |
| May 27, 2026 | May 29 9:54 PM | Sandra MilliganDirector | Grant/Award | 8,026 | $72.51 | 8,026(D) | View → |
| May 1, 2026 | May 2 1:35 AM | Scott L BurrowsChief Financial Officer | Option Exercise | 12,500 | $14.50 | 382,357(D) | View → |
| May 1, 2026 | May 2 1:34 AM | Sheldon SloanChief Medical Officer | Option Exercise | 78,333 | $27.46 | 321,667(D) | View → |
| Mar 3, 2026 | Mar 4 2:32 AM | Scott L BurrowsChief Financial Officer | Option Exercise | 2,500 | $14.50 | 402,357(D) | View → |